Literature DB >> 18825310

Prognostic value of extracapsular invasion and fibrotic focus in single lymph node metastasis of gastric cancer.

Takahide Okamoto1, Akira Tsuburaya, Yoichi Kameda, Takaki Yoshikawa, Haruhiko Cho, Kazuhito Tsuchida, Shinichi Hasegawa, Yoshikazu Noguchi.   

Abstract

BACKGROUND: Histological findings of metastatic lymph nodes are important prognosticators in patients with gastric cancer. The aim of this study was to clarify the clinical significance of various pathological characteristics of the early phase of lymph node metastasis in patients with gastric cancer, by selecting patients with tumors that had single lymph node metastases, no serosal invasion, and no metastases to the peritoneum, liver, or distant organs.
METHODS: Seventy-eight patients were eligible and were entered in this study. These patients were subdivided according to the following histological characteristics of the one metastatic lymph node: size of the metastasis (i.e., amount of tumor cells [AT]), proliferating pattern (PP), intranodal location (IL), and the presence or absence of extracapsular invasion (ECI) and/or fibrotic focus (FF). Associations between clinicopathological factors, survival, and the nodal findings were examined.
RESULTS: There were no correlations between AT or PP and any clinicopathological factors. IL was significantly correlated with venous invasion and the pathological characteristics of the primary tumor. ECI and FF were observed significantly more frequently in pT2 than in pT1 cancer. Overall survival (OS) differed significantly according to depth of invasion, venous invasion, and the presence or absence of ECI or FF, although OS was not affected by AT, PP, or IL. The 10-year overall survival rates of patients with and without ECI were 50% and 80%, respectively, while these rates for patients with and without FF were 50% and 79%, respectively. Multivariate analysis revealed that ECI and FF were significant prognosticators of survival.
CONCLUSION: These results strongly suggested that the presence of ECI or FF could affect the survival of patients with gastric cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18825310     DOI: 10.1007/s10120-008-0473-8

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  19 in total

1.  Peritoneal metastasis in gastric cancer with particular reference to lymphatic advancement; extranodal invasion is a significant risk factor for peritoneal metastasis.

Authors:  T Tanaka; K Kumagai; K Shimizu; K Masuo; K Yamagata
Journal:  J Surg Oncol       Date:  2000-11       Impact factor: 3.454

2.  Clinicopathological analysis of early gastric cancer with solitary lymph node metastasis.

Authors:  K Arai; Y Iwasaki; T Takahashi
Journal:  Br J Surg       Date:  2002-11       Impact factor: 6.939

3.  Extranodal metastasis is an indicator of poor prognosis in patients with gastric carcinoma.

Authors:  T Etoh; M Sasako; K Ishikawa; H Katai; T Sano; T Shimoda
Journal:  Br J Surg       Date:  2006-03       Impact factor: 6.939

4.  Surgical treatment of gastric malignancies: a twenty-year series comprising mainly far advanced and high-seated tumors.

Authors:  A Zacho; C Cederqvist; K Fischerman
Journal:  Ann Surg       Date:  1974-01       Impact factor: 12.969

5.  Protein levels of tissue inhibitor of metalloproteinase-1 in tumor extracts as a marker for prognosis and recurrence in patients with gastric cancer.

Authors:  Takaki Yoshikawa; Akira Tsuburaya; Osamu Kobayashi; Motonori Sairenji; Yohei Miyagi
Journal:  Gastric Cancer       Date:  2006       Impact factor: 7.370

6.  Clinicopathological value of immunohistochemical detection of occult involvement in pT3N0 gastric cancer.

Authors:  Jianhui Cai; Masahide Ikeguchi; Michio Maeta; Nobuaki Kaibara; Takashi Sakatani
Journal:  Gastric Cancer       Date:  1999-08       Impact factor: 7.370

7.  Solitary lymph node metastasis of gastric cancer as a basis for sentinel lymph node biopsy.

Authors:  Akira Tsuburaya; Yoshikazu Noguchi; Takaki Yoshikawa; Osamu Kobayashi; Motonori Sairenji; Hisahiko Motohashi
Journal:  Hepatogastroenterology       Date:  2002 Sep-Oct

8.  Are axillary recurrence and overall survival affected by axillary extranodal tumor extension in breast cancer? Implications for radiation therapy.

Authors:  C Leonard; M Corkill; J Tompkin; B Zhen; D Waitz; L Norton; J Kinzie
Journal:  J Clin Oncol       Date:  1995-01       Impact factor: 44.544

9.  Occult axillary lymph node metastases are of no prognostic significance in breast cancer.

Authors:  R R Millis; R Springall; A H S Lee; K Ryder; E R C Rytina; I S Fentiman
Journal:  Br J Cancer       Date:  2002-02-01       Impact factor: 7.640

10.  Occult axillary node metastases in breast cancer: their detection and prognostic significance.

Authors:  M A McGuckin; M C Cummings; M D Walsh; B G Hohn; I C Bennett; R G Wright
Journal:  Br J Cancer       Date:  1996-01       Impact factor: 7.640

View more
  10 in total

1.  Process of distant lymph node metastasis in colorectal carcinoma: implication of extracapsular invasion of lymph node metastasis.

Authors:  Takaaki Fujii; Yuichi Tabe; Reina Yajima; Satoru Yamaguchi; Soichi Tsutsumi; Takayuki Asao; Hiroyuki Kuwano
Journal:  BMC Cancer       Date:  2011-06-02       Impact factor: 4.430

Review 2.  Gastrointestinal cancer metastasis and lymphatic advancement.

Authors:  Kazuhide Kumagai; Kouji Shimizu; Noboru Yokoyama; Sadatsugu Aida; Takayuki Tanaka; Kennichi Yamagata
Journal:  Surg Today       Date:  2010-03-26       Impact factor: 2.549

Review 3.  Extranodal Extension of Nodal Metastases Is a Poor Prognostic Indicator in Gastric Cancer: a Systematic Review and Meta-analysis.

Authors:  Nicola Veronese; Matteo Fassan; Laura D Wood; Brendon Stubbs; Marco Solmi; Paola Capelli; Antonio Pea; Alessia Nottegar; Giuseppe Sergi; Enzo Manzato; Sara Carraro; Marco Maruzzo; Ivana Cataldo; Fabio Bagante; Mattia Barbareschi; Liang Cheng; Maria Bencivenga; Giovanni de Manzoni; Claudio Luchini
Journal:  J Gastrointest Surg       Date:  2016-07-13       Impact factor: 3.452

4.  ASO Author Reflections: Extracapsular Extension of Lymph Node: An Important Consideration for Gastric Cancer.

Authors:  Bofei Li; Anthony W I Lo; Simon Law
Journal:  Ann Surg Oncol       Date:  2020-05-07       Impact factor: 5.344

5.  Extracapsular invasion as a risk factor for disease recurrence in colorectal cancer.

Authors:  Takaaki Fujii; Yuichi Tabe; Reina Yajima; Satoru Yamaguchi; Soichi Tsutsumi; Takayuki Asao; Hiroyuki Kuwano
Journal:  World J Gastroenterol       Date:  2011-04-21       Impact factor: 5.742

6.  Impact of Extracapsular Extension of Lymph Node in Adenocarcinoma of the Stomach.

Authors:  Bofei Li; Ian Yu-Hong Wong; Fion Siu-Yin Chan; Kwan Kit Chan; Claudia Lai-Yin Wong; Tsz-Ting Law; Jeanette Yat-Yin Kwok; Anthony Wing Ip Lo; Simon Law
Journal:  Ann Surg Oncol       Date:  2020-05-05       Impact factor: 5.344

Review 7.  The rationale for targeting the LOX family in cancer.

Authors:  Holly E Barker; Thomas R Cox; Janine T Erler
Journal:  Nat Rev Cancer       Date:  2012-07-19       Impact factor: 60.716

8.  Evaluation of extra capsular lymph node involvement in patients with extra-hepatic bile duct cancer.

Authors:  Takehiro Noji; Masaki Miyamoto; Kanako C Kubota; Toshiya Shinohara; Yoshiyasu Ambo; Yoshihiro Matsuno; Nobuichi Kashimura; Satoshi Hirano
Journal:  World J Surg Oncol       Date:  2012-06-08       Impact factor: 2.754

9.  Extracapsular invasion of sentinel lymph nodes is not associated with disease recurrence in breast cancer.

Authors:  Takaaki Fujii; Reina Yajima; Satoru Yamaguchi; Yasuhiro Yanagita; Tomomi Fujisawa; Tomoko Hirakata; Soichi Tsutsumi; Takayuki Asao; Misa Iijima; Hiroyuki Kuwano
Journal:  Int Surg       Date:  2014 Jul-Aug

10.  Extranodal soft tissue metastasis as an independent prognostic factor in gastric cancer patients aged under 70 years after curative gastrectomy.

Authors:  Nannan Zhang; Jingyu Deng; Weilin Sun; Yingxin Du; Shiwei Guo; Huihui Bai; Huifang Liu; Han Liang
Journal:  Ann Transl Med       Date:  2020-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.